Final results of a multicenter phase II trial assessing the activity and efficacy of helicobacter pylori-eradicating antibiotic therapy as exclusive treatment for patients with stage I-II1 diffuse large b-cell lymphoma of the stomach (the HGL-1 trial)

Authors
Category Primary study
JournalBlood
Year 2011
This article has no abstract
Epistemonikos ID: 10c69a1950fd5a5609439e56f06585f23986d1ec
First added on: Feb 05, 2025